Transaction · 0001960048-26-000009

Cowan Elvia

Cowan Elvia, SVP, CAO, reported a transaction classified as withholding at Vaxcyte, Inc. involving 326.000000 shares for an estimated $20075.08. Reported holdings after the transaction were 29187.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FSVP, CAO
PCVXVaxcyte, Inc.
Filing timeSep 02
Trade dateSep 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$62.56
Pre-filing
1mo ago -14.4%1w ago +0.0%1d ago +0.0%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

PCVX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PCVX since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001960048-26-000009
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 02, 2026, 11:54 PM · 0d delay
Shares
326 sh
$6.15k per share
Estimated value
-$2.00M
Computed from shares × price
Holdings after
29.1k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, Finance & CAO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.

  2. F2

    Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.

Original filing · 0001960048-26-000009
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PCVX